Clinical Trials
- February 10, 2012
- The Long-term Safety and Efficacy of Olokizumab (CDP6038) With Active Rheumatoid Arthritis
- Condition: Rheumatoid Arthritis
Intervention: Biological: Olokizumab
Sponsor: UCB, Inc.
Enrolling by invitation - verified February 2012
- February 10, 2012
- The Effects of Cardiac Rehabilitation on Cardiovascular Disease Risk in Rheumatoid Arthritis Patients
- Condition: Rheumatoid Arthritis
Intervention: Behavioral: Exercise
Sponsor: Capital District Health Authority, Canada
Not yet recruiting - verified February 2012
- February 8, 2012
- Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis
- Condition: Rheumatoid Arthritis
Intervention: Biological: rituximab
Sponsor: Celltrion
Not yet recruiting - verified February 2012
